Robinson Value Management, Ltd. Gilead Sciences, Inc. Transaction History

Robinson Value Management, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $967,495 - $1.06 Million	-15,701 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $27,284 - $30,596	-441 Reduced 2.73%	15,701 $1.06 Million
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $322,827 - $357,428	-4,529 Reduced 21.91%	16,142 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $48,530 - $56,608	-748 Reduced 3.49%	20,671 $0
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $27,169 - $33,122	-373 Reduced 1.71%	21,419 $1.62 Million
Q4 2017 Jan 18, 2018	SELL	$71.15 - $83.52 $49,093 - $57,628	-690 Reduced 3.07%	21,792 $1.56 Million
Q3 2017 Nov 16, 2017	BUY	$72.11 - $85.47 $1.62 Million - $1.92 Million	22,482	22,482 $1.82 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Robinson Value Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Robinson Value Management, Ltd. with notifications on news.